American Chemical Society and Max Planck institutes partner on transformative open access plan

29 Mar 2019

The agreement is a notable development in open access publishing for ACS, as well as for the Max Planck Society’s own transition strategy. “ACS is among the most-relevant publishers for Max Planck Society researchers; this new agreement is an exciting opportunity for our authors to achieve the greatest visibility possible by publishing their accepted articles open access within the ACS journals that they highly value,” says Gerard Meijer, Ph.D., director of the Max Planck Society’s Fritz Haber Institute in Berlin. Ralf Schimmer, Ph.D., head of Information Provision at MPDL adds, “This is an exemplary illustration of how scholarly societies can partner with libraries to test new economic models that enable societies to continue their precious contributions to science while transitioning to a future-oriented model of scholarly communication. This new agreement with the ACS is another important milestone in our broader open access transformation strategy and enables the MPDL to convert former subscription expenditures into funds that, instead, support open access publishing, in line with the Open Access 2020 Initiative.”
 

The partnership represents a significant milestone as ACS progressively develops its established and significant suite of open access publishing options and author services. “We are committed to supporting researchers in publishing open access in the journal of their choice, while ensuring the quality, reliability and preservation of the scholarly record,” says James Milne, Ph.D., senior vice president, Journals Publishing Group at ACS Publications. “This agreement with the Max Planck Society ensures their world-class researchers can publish in any ACS journal, knowing that their research will benefit from being among the ‘most-cited, most-trusted and most-read’ scientific publications worldwide.”